KalVista Pharmaceuticals, Inc. (KALV): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0001214659-26-010418

Filer

KalVista Pharmaceuticals, Inc. (CIK 1348911)